Duke Clinical Research Unit (DCRU)
The Duke Clinical Research Unit (DCRU) is one of just a handful of state-of-the-art hospital-based early phase research units in the country. The creation of the DCRU enables Duke investigators to conduct proof-of-concept research, including efforts to identify and validate novel biomarkers, while leveraging advances at the forefront of technology. In addition to early-stage investigator-initiated studies and NIH-funded research, Duke researchers also work with pharmaceutical, biotechnology, and medical device companies to generate data.
DCRU is part of the Duke Clinical Research Institute. The DCRI is a comprehensive academic research organization (ARO) and the only one of its kind that can offer all the services of a commercial contract research organization (CRO) with the academic credibility and expertise of an academic research institute.
Collaborating with similar ultra-modern, early-phase units, DCRU works with the recently established Medanta Duke Research Institute (MDRI) in New Delhi, India, and the early phase research unit in Singapore General Hospital through a collaboration with the Duke-National University of Singapore Graduate Medical School.
Building on the strength of Duke's thought leadership, therapeutic expertise, patient base, and access to the latest technologies, the DCRU is a critical component of the Duke Translational Medicine Institute's efforts to speedily translate new laboratory discoveries into treatments for patients.
- To schedule research at the DCRU, please call 919-668-2262.
There are currently no items in this folder.